 |
leapta-lifesciences.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
208 days |
|
PD-449062 |
Feb 2024 |
Jun 2024 |
128 days |
|
 |
lnp-immunogenicity-toxicity-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
189 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
146 days |
|
 |
mrna-analytical-development-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
282 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
30 days |
|
 |
advancing-life-science-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
ras-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
146 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
73 days |
|
 |
operationalize-eap.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
162 days |
|
 |
proteindegradation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
134 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
85 days |
|
 |
lipid-nanoparticle-delivery-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
342 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
283 days |
|
 |
lipid-nanoparticle-development-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
260 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
83 days |
|
 |
rnaibased-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
205 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
164 days |
|
 |
advancing-ocean-cdr.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Apr 2024 |
Feb 2025 |
289 days |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
265 days |
|
 |
adc-targetselection.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
175 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
160 days |
|
 |
adc-process-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
265 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
77 days |
|
 |
allogeneic-cell-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
245 days |
|
 |
antibody-fusion-protein.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Apr 2024 |
Jul 2024 |
103 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jul 2024 |
89 days |
|
 |
advanced-procurement-in-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
353 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
 |
spatial-biology-immuno-oncology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
219 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
165 days |
|
 |
advanced-manufacturing-facilities.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
277 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
41 days |
|
 |
strain-engineering-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
146 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jul 2024 |
84 days |
|
 |
structure-based-drug-design-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Apr 2024 |
Oct 2024 |
188 days |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
159 days |
|
 |
til-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
159 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
14 days |
|
 |
viral-vector-process-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
207 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
167 days |
|
 |
wet-amd-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Mar 2024 |
Oct 2024 |
208 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
cannabinoid-derived-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
195 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
139 days |
|
 |
cdd-biologics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
233 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
104 days |
|
 |
cell-therapy-autoimmune-disease.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
195 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
140 days |
|
 |
adc-analytical.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
 |
cytokine-based-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
275 days |
|
|
MK-355-DOS-429 |
Jan 2025 |
Feb 2025 |
8 days |
|
 |
dermatology-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
249 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
91 days |
|
 |
esg-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
12 days |
|
 |
genetherapy-immunogenicity.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
261 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
81 days |
|
 |
genetherapy-patient-engagement.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
fc-function-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
50 days |
|
|
PD-449062 |
Dec 2024 |
Feb 2025 |
50 days |
|
 |
hpapi-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
kinase-inhibitors-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
164 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Oct 2024 |
45 days |
|
 |
leaphr-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
189 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
146 days |
|
 |
in-house-impact-life-sciences.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
43 days |
|
|
PD-449062 |
Dec 2024 |
Feb 2025 |
43 days |
|
 |
molecular-glue-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
185 days |
|
 |
mrna-processandmanufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
282 days |
|
 |
cartcr-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
237 days |
|
 |
dna-process-development-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
253 days |
|
 |
fermentation-enabled-proteins.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
247 days |
|
 |
leap-hr-lifesciences-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Mar 2024 |
Feb 2025 |
330 days |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
226 days |
|
 |
leaphr-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
271 days |
|
|
PD-449062 |
Feb 2024 |
Apr 2024 |
71 days |
|
 |
ligase-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
165 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Aug 2024 |
97 days |
|
 |
liquid-biopsy-summit-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Aug 2024 |
82 days |
|
|
PD-449062 |
May 2024 |
Aug 2024 |
82 days |
|
 |
advancing-computational-design.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
209 days |
|
 |
advancing-construction-decarbonization.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
338 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
leaphr-highereducation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
165 days |
|
 |
medicaldevice-software-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
337 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
283 days |
|
 |
medicaldevicesummit-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
202 days |
|
 |
microbiome-agbiotech.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
microbiome-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
350 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
282 days |
|
 |
mrnabased-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
282 days |
|
 |
neoantigen-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
162 days |
|
 |
neuropsychiatric-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
146 days |
|
|
PD-449062 |
Feb 2024 |
Apr 2024 |
72 days |
|
 |
next-gen-rna.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
162 days |
|
 |
ehs-medicaldevices.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
213 days |
|
|
PD-449062 |
Jul 2024 |
Feb 2025 |
213 days |
|
 |
nonviral-rna-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
158 days |
|
 |
mrna-analytical-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
 |
mitochondria-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
225 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
110 days |
|
 |
advancing-construction-tech.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
operationalise-early-access.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Jun 2024 |
Oct 2024 |
119 days |
|
 |
leaphr-retail.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
228 days |
|
 |
precision-medicine-in-ibd.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
231 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
163 days |
|
 |
rare-kidney-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
112 days |
|
|
MK-355-DOS-429 |
Jun 2024 |
Oct 2024 |
100 days |
|
 |
lbx-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
261 days |
|
 |
advancing-project-controls.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
222 days |
|
 |
rna-assay-development-screening.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
232 days |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
159 days |
|
 |
advancing-building-commissioning.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
344 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jan 2025 |
276 days |
|
 |
tgf-beta-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
134 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
86 days |
|
 |
tumor-models-sf.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
221 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
tumor-models.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
tumour-models.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
172 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Oct 2024 |
43 days |
|
 |
bispecific.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Feb 2024 |
3 days |
|
 |
viral-vector-process-development-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
worldadc-asia.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
cell-therapy-analytics-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days
|
|
 |
cell-therapy-supply-chain-logistics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
237 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
169 days |
|
 |
real-world-evidence-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Oct 2024 |
119 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
97 days |
|
 |
gpcrs-drugdiscovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
335 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
computational-rna-design-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
176 days |
|
|
PD-449062 |
Aug 2024 |
Feb 2025 |
176 days |
|
 |
fermentation-enabled-protein-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
 |
genetherapy-muscular.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
162 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Dec 2024 |
119 days |
|
 |
gxp-cloudcompliance.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
273 days |
|
|
PD-449062 |
Feb 2024 |
Apr 2024 |
70 days |
|
 |
integrated-project-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
190 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
144 days |
|
 |
leaphr-government.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
bioactive-infant-nutrition.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
215 days |
|
|
PD-449062 |
Jul 2024 |
Jan 2025 |
206 days |
|
 |
leaphr-oilandenergy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
323 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jan 2025 |
255 days |
|
 |
advancing-construction-planning-scheduling.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
217 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
119 days |
|
 |
advancing-construction-quality.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Apr 2024 |
52 days |
|
 |
car-tcr-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
cdx-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
270 days |
|
 |
leap-hr-lifesciences-west.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
273 days |
|
 |
cns-drug-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
177 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
159 days |
|
 |
complement-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
176 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
159 days |
|
 |
adc-linker-conjugation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
leaptd-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
226 days |
|
|
PD-449062 |
Jun 2024 |
Feb 2025 |
226 days |
|
 |
advancing-data-center-construction-west.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
61 days |
|
 |
advancing-construction-safety-leadership.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
 |
advancing-prefabrication.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
209 days |
|
 |
bacteriophage-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
251 days |
|
 |
afdd-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
217 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
119 days |
|
 |
spatialbiology-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
114 days |
|
|
MK-355-DOS-429 |
Jun 2024 |
Oct 2024 |
100 days |
|
 |
advancing-construction-operational-excellence.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
 |
adc-payload.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
217 days |
|
|
PD-449062 |
Jul 2024 |
Dec 2024 |
166 days |
|
 |
advancing-mep-management.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
235 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
102 days |
|
 |
sting-tlr-targeting-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
233 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
165 days |
|
 |
adc-toxicity.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
tpd-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
treg-directed-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
world-cdx-regulatory-affairs-policy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
158 days |
|
|
PD-449062 |
May 2024 |
Oct 2024 |
158 days |
|
 |
world-cdx.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
133 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
88 days |
|
 |
worldadc-usa.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
159 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
27 days |
|
 |
capital-project-engineering.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
159 days |
|
 |
cell-therapy-potency-assay.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
237 days |
|
 |
commercializing-flow-chemistry.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
232 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
104 days |
|
 |
continuous-processing-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
225 days |
|
 |
covalent-drug-discovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
214 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
122 days |
|
 |
microbiome-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
216 days |
|
 |
decentralized-manufacturing-celltherapy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
160 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jul 2024 |
92 days |
|
 |
digital-biomarkers-neurology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
 |
gamma-delta-t-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
15 days |
|
 |
inflammasome-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
261 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
81 days |
|
 |
ipf-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
dry-amd-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
213 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
123 days |
|
 |
leap-hr-lifesciences-east.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
283 days |
|
 |
leaphr-lifesciences-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
215 days |
|
 |
leapta-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
202 days |
|
 |
leaphr-healthcare.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Dec 2024 |
317 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
advancing-preconstruction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
61 days |
|
 |
leaphr-emerging-biopharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
208 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
128 days |
|
 |
mrna-quality-control.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
158 days |
|
 |
neuroimmunology-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
217 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
162 days |
|
 |
next-gen-conjugates.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
162 days |
|
 |
next-gen-genetherapy-vectors.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
158 days |
|
 |
retinal-imaging-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
232 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
164 days |
|
 |
ipsc-therapies-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
20 days |
|
 |
oligonucleotides-cns.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
158 days |
|
 |
oligos-cmc-analytical-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
158 days |
|
 |
ophthalmic-drug-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
204 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
162 days |
|
 |
heartfailuresummit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
|
PD-449062 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
leaphr-logistics-transportation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
process-development-celltx.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
231 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
163 days |
|
 |
ckd3-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
265 days |
|
 |
inner-ear-disorders-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
210 days |
|
|
PD-449062 |
Jul 2024 |
Feb 2025 |
210 days |
|
 |
lnp-characterization-analytical-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
208 days |
|
|
PD-449062 |
Apr 2024 |
Jun 2024 |
57 days |
|
 |
advancing-design-quality-management.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
325 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
advancing-aec-knowledge-management.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
252 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
89 days |
|
 |
rna-drugdiscovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
150 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Oct 2024 |
63 days |
|
 |
rnaediting-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
232 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
164 days |
|
 |
als-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Dec 2024 |
293 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
innate-killer.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
201 days |
|
 |
targeted-intracellular-delivery-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
152 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jul 2024 |
84 days |
|
 |
targeted-radiopharma-manufacturing-supplychain.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
99 days |
|
|
MK-355-DOS-429 |
Jun 2024 |
Jun 2024 |
One Off |
|
 |
targeted-radiopharma-us.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
233 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
165 days |
|
 |
targeted-radiopharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
152 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Oct 2024 |
62 days |
|
 |
age-related-disease.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
353 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
 |
worldadc-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
221 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
166 days |
|
 |
cell-engager-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
cell-therapy-analytics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
195 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
140 days |
|
 |
allogeneic-cell-therapies-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
crispr-agbio-congress.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
238 days |
|
 |
cultivated-meat-seafood-bioprocessing-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
347 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
dermatology-drugdevelopment-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jan 2025 |
347 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
 |
ehs-biopharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
265 days |
|
 |
ddr-inhibitors-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
197 days |
|
 |
esg-lifesciences.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
230 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
92 days |
|
 |
fluid-imaging-biomarkers-neuro.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
230 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
106 days |
|
 |
genetherapy-analytical-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
280 days |
|
 |
genetherapy-cns.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
211 days |
|
|
PD-449062 |
Jun 2024 |
Jun 2024 |
One Off |
|
 |
genetherapy-comparability.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
genetherapy-potency-assay.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
|
PD-449062 |
Apr 2024 |
Nov 2024 |
210 days |
|
 |
lab-asset-in-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
227 days |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
109 days |
|
 |
lab-asset-facility-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
267 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Nov 2024 |
205 days |
|
 |
leap-hr-healthcare-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Apr 2024 |
Feb 2025 |
283 days |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
226 days |
|
 |
leap-ta-retail.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
226 days |
|
|
PD-449062 |
Jun 2024 |
Feb 2025 |
226 days |
|
 |
leapta-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Dec 2024 |
306 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
leapta-healthcare.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
170 days |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
165 days |
|
 |
lnp-formulation-process-development-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
249 days |
|
|
MK-355-DOS-429 |
Oct 2024 |
Feb 2025 |
98 days |
|
 |
advancing-construction-analytics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
 |
macrophage-directed-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
283 days |
|
|
PD-449062 |
Feb 2024 |
Apr 2024 |
55 days |
|
 |
measuring-patient-engagement-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
278 days |
|
 |
next-gen-inhalation-delivery-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Oct 2024 |
13 days |
|
|
PD-449062 |
Sep 2024 |
Oct 2024 |
13 days |
|
 |
advancing-data-center-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
198 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
137 days |
|
 |
optimizing-hybrid-clinical-trials.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
161 days |
|
|
PD-449062 |
Apr 2024 |
May 2024 |
15 days |
|
 |
pfs-injectables.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Oct 2024 |
135 days |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
35 days |
|
 |
process-analytical-technology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
168 days |
|
|
MK-355-DOS-429 |
Aug 2024 |
Oct 2024 |
44 days |
|
 |
real-world-evidence-pharma-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
231 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Oct 2024 |
163 days |
|
 |
genetherapy-conference.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
241 days |
|
 |
mrna-processandmanufacturing-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Dec 2024 |
296 days |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
52 days |
|
 |
advancing-mep-estimating.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
198 days |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
137 days |
|
 |
alzheimers-parkinsons-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
245 days |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
61 days |
|
 |
advancing-mass-timber.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
235 days |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
102 days |
|
 |
glp-1-based-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Nov 2024 |
Feb 2025 |
78 days |
|
|
PD-449062 |
Nov 2024 |
Dec 2024 |
11 days |
|
 |
mrnabased-therapeutics-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
203 days |
|
 |
glioblastoma-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
241 days |
|
 |
induced-proximity-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
leaptd-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
189 days |
|
 |
novel-combination-immunotherapy-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Oct 2024 |
34 days |
|
 |
esg-sustainability-realestate.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
212 days |
|
 |
cell-gene-therapy-medical-affairs.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
177 days |
|
 |
cell-gene-therapy-regulatory.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
214 days |
|
 |
in-vivo-engineering.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
43 days |
|
 |
ehss-biopharma-west.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Oct 2024 |
Feb 2025 |
113 days |
|
 |
hit-id-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Oct 2024 |
Feb 2025 |
106 days |
|
 |
hansonwade-intelligence.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
industrializingcultivatedmeats.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
kinase-drug-discovery-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Feb 2025 |
Feb 2025 |
5 days |
|
 |
innovation-obesity-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Feb 2025 |
140 days |
|
 |
hansonwadegroup.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
crispr-analytical-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jan 2025 |
Feb 2025 |
8 days |
|
 |
liquid-biopsy-surveillance-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Feb 2025 |
152 days |
|
 |
mrna-assaydevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
147 days |
|
 |
mrna-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
147 days |
|
 |
practical-ai-drug-discovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Sep 2024 |
204 days |
|
 |
adc-pdm-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Mar 2024 |
Jul 2024 |
115 days |
|
 |
biologic-oral-biovailability-formulation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
158 days |
|
 |
decentralized-clinical-trials.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2024 |
8 days |
|
 |
genetherapy-neurological.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
107 days |
|
 |
leaphr-hospitality.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
 |
alternative-protein-dsp-formulation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
194 days |
|
 |
genetherapy-ophthalmology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
284 days |
|
 |
genetherapy-analytical-cmc.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
229 days |
|
 |
supply-chain-logistics-cgt.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Nov 2024 |
Feb 2025 |
95 days |
|
 |
microbiome-cosmeceuticals.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
Feb 2025 |
259 days |
|
 |
leap-ta-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
184 days |
|
 |
microbiome-animal-health.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
110 days |
|
 |
optimizing-aav-safety.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
84 days |
|
 |
animal-vaccine-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
157 days |
|
 |
adenosine-pathway-immunotherapy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
236 days |
|
 |
synthetic-biology-therapeutics-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
152 days |
|
 |
tumor-myeloid-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
 |
microbiome-nutrition.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
 |
gtx-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
162 days |
|
 |
her2-targeted-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
 |
leaphr-financialservices.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Feb 2025 |
354 days |
|
 |
3d-tissuemodels.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
40 days |
|
 |
sugar-reduction-reformulation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Oct 2024 |
13 days |
|
 |
biopharma-portfolio-strategy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Aug 2024 |
Feb 2025 |
178 days |
|
 |
cell-therapy-neurological.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Oct 2024 |
Feb 2025 |
117 days |
|
 |
gpcrs-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
49 days |
|
 |
exosomebased-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
285 days |
|
 |
advancingconstruction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
genetherapy-analytical.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jun 2024 |
37 days |
|
 |
genome-editing-therapeutics-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Feb 2025 |
157 days |
|
 |
hansonwade.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Jan 2025 |
269 days |
|
 |
leap-hr-construction-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
208 days |
|
 |
leaphr-energy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jan 2025 |
Feb 2025 |
18 days |
|
 |
proteomic-drug-discovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Oct 2024 |
Oct 2024 |
One Off |
|
 |
bioactive-functional-fb.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Feb 2025 |
144 days |
|
 |
as-immunetolerance.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jan 2025 |
Feb 2025 |
21 days |
|
 |
advancing-data-centre-construction-uk-ireland.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jan 2025 |
Feb 2025 |
35 days |
|
 |
advancing-electrical-prefabrication.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
217 days |
|
 |
advanced-purification-complex-biologics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
156 days |
|
 |
allo-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
175 days |
|
 |
tpd-assays-screening.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
134 days |
|
 |
tpd-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
153 days |
|
 |
crispr-conference.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
160 days |
|
 |
dsp-alternative-proteins-cellular-agriculture.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
141 days |
|
 |
gene-editing-delivery-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
107 days |
|
 |
genetherapy-blood.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
162 days |
|
 |
genetherapy-neurological-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
162 days |
|
 |
leap-hrbp-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
184 days |
|
 |
lifesciences-fpa-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
25 days |
|
 |
microbiome-dermatology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Mar 2024 |
28 days |
|
 |
adc-partnering.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Oct 2024 |
Feb 2025 |
118 days |
|
 |
adc-pharmacokinetics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Dec 2024 |
Feb 2025 |
61 days |
|
 |
targeted-radiopharma-supplychain-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Oct 2024 |
99 days |
|
 |
beacon-intelligence.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
May 2024 |
May 2024 |
One Off |
|
 |
car-tcr-cell-therapy-summit-asia.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Feb 2025 |
215 days |
|
 |
leap-hr.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Apr 2024 |
Feb 2025 |
286 days |
|
 |
mashdrugdevelopmentsummit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jun 2024 |
Feb 2025 |
243 days |
|
 |
personalized-cancer-vaccines.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Jul 2024 |
Oct 2024 |
103 days |
|
 |
cdx-lbx-summit-apac.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Sep 2024 |
Feb 2025 |
158 days |
|
 |
lab-ops-facility-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
MK-355-DOS-429 |
Nov 2024 |
Feb 2025 |
77 days |
|
 |
adc-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
156 days |
|
 |
tcr-therapies-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
233 days |
|
 |
translatable-models-neuroscience.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
115 days |
|
 |
viral-vector-analytical-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
87 days |
|
 |
worldadc-awards.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
234 days |
|
 |
innate-killer-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
126 days |
|
 |
lbx-surveillance-early-detection-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Aug 2024 |
165 days |
|
 |
lnp-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
128 days |
|
 |
microbiome-infant-health.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Nov 2024 |
278 days |
|
 |
microbiome-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
147 days |
|
 |
mrna-cancer-vaccine.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jun 2024 |
129 days |
|
 |
nasal-formulation-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
 |
obesity-and-nash-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
84 days |
|
 |
oncolytic-virotherapy-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Oct 2024 |
230 days |
|
 |
predictive-biomarkers-cell-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
May 2024 |
97 days |
|
 |
ras-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
|
PD-449062 |
Feb 2024 |
Jul 2024 |
150 days |
|